Bender MedSystems

Bender MedSystems is a biotechnology company specializing in the development and manufacture of high-quality research reagents, particularly in the fields of immunology and cell biology. Originally a spin-off from Boehringer Ingelheim, the company became well-known for its proprietary Instant ELISA technology and FlowCytomix multiplexing kits. Their product portfolio includes a wide range of enzyme-linked immunosorbent assays, recombinant proteins, and monoclonal antibodies targeting cytokines, adhesion molecules, and apoptosis markers. Following its acquisition by eBioscience and subsequently Thermo Fisher Scientific, its technologies have been integrated into the Invitrogen brand. The company serves the global life sciences research community from its base in Vienna, Austria.